To make an award under HHS-NIH-niaid-BAA2018

Ended Definitive Contract Awarded Last action

Contract number
75N93019C00060
Awardee
Awarding agency
Obligated
$16,754,610

Award facts

Opportunity
Contract value 74% obligated
  • $16,754,609.82 Current, with exercised options
  • $22,595,588.82 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 12 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Lowell, MA 01852, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00031 · Development of medical countermeasures for biothreat agents, antimicrobial-resistant infections and emerging infectious diseases. $955,166
Terminate for Convenience P00030 · EOI::implementing the presidents department of government efficiency cost efficiency initiative (march 19, 2025)::EOI development of medical countermeasures for… $0
Other Administrative Action P00029 $0
Exercise an Option P00028 $1,691,805
Funding Only Action P00027 $384,150
Exercise an Option P00026 $1,051,310
Exercise an Option P00025 $481,161
Other Administrative Action P00024 $0
Other Administrative Action P00023 $0
Other Administrative Action P00022 $597,134
Exercise an Option P00021 $2,491,065
Other Administrative Action P00020 $0
Funding Only Action P00019 $700,931
Other Administrative Action P00018 $213,723
Other Administrative Action P00017 $0
Other Administrative Action P00016 $0
Funding Only Action P00015 $394,220
Funding Only Action P00014 $498,776
Other Administrative Action P00013 $0
Other Administrative Action P00012 $0
Other Administrative Action P00011 $0
Funding Only Action P00010 $275,277
Exercise an Option P00009 $441,947
Other Administrative Action P00008 $0
Other Administrative Action P00007 $0
Other Administrative Action P00006 $0
Funding Only Action P00005 $676,903
Other Administrative Action P00004 $0
Change Order P00003 $0
Exercise an Option P00002 $3,802,918
Other Administrative Action P00001 · To advance the lead universal influenza vaccine candidate through a phase I clinical study and to evaluate safety and long-term immunogenicity with one and / or… $0
Original award $2,098,124
Show all 32

About this award

Written by GovTribe AI ·

The National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIH NIAID) awarded a $22,595,588.82 cost-plus-fixed-fee definitive contract to Versatope Therapeutics Inc., a for-profit biotechnology company based in Lowell, Massachusetts. This contract, awarded under the HHS-NIH-NIAID-BAA2018 program, supports research to establish and improve biomedical knowledge on infectious diseases such as malaria. The contract has an ultimate completion date of June 28, 2025. Versatope Therapeutics Inc. was also awarded a $999,762 project grant from NIH NIAID to advance the development of its recombinant outer membrane vesicle (ROMV) platform as a novel adjuvant for a malaria vaccine. No set-aside designation was applied to this contract award.

Quick answers

Who was awarded contract 75N93019C00060?

75N93019C00060 was awarded to Versatope Therapeutics Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 4, 2019.

How much is contract 75N93019C00060 worth?

The government has obligated $16,754,610 on 75N93019C00060. Its potential value, with all options, is $22,595,589.

Was contract 75N93019C00060 competed?

The extent of competition for 75N93019C00060 was full and open competition. The government received 12 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login